ALS Drug Development Summit
24
May
-
26
May
2022
When
Boston
Massachusetts
USA
Where

Meaningful progress in establishing causative genetic mutations and environmental factors implicated in ALS disease progression and advances in validating emerging biomarkers to evaluate treatment response has meant that the landscape for drug development in ALS is exploding.

Similar Events

You May Like

Event

Hanson Wade

0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

24 - 26 May 2022
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Senior Vice President; Senior Fellow, Clinical Research and Development
Chief Medical Officer
Professor and Chair of Neurology
Chief Development Officer
Director Translational Medicine
Founder and CEO of QurAlis

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Worldwide Clinical Trials

Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way.

Genomenon, Inc

Genomenon is a genomic health IT company that keeps pace with the constant advancements made in genomics and connects that research to patient DNA to help diagnose and treat patients with rare genetic diseases and cancer.

Julius Clinical

At Julius Clinical, science is the foundation. Combined with flexibility, creativity, and innovation, our scientific approach enables fast, efficient, and high quality execution of complex clinical development programs.

NeuroSYS

We are a bunch of tech enthusiasts who deliver custom IT solutions in a predictable way. We help businesses bring their ideas to life from scratch, as well as rescue ongoing projects.

Organizer

Get emails from us

Thank you
Oops! Something went wrong